EA202191302A1 - COMBINATION OF Mcl-1 INHIBITOR AND MIDOSTAURINE, ITS APPLICATIONS AND PHARMACEUTICAL COMPOSITIONS - Google Patents

COMBINATION OF Mcl-1 INHIBITOR AND MIDOSTAURINE, ITS APPLICATIONS AND PHARMACEUTICAL COMPOSITIONS

Info

Publication number
EA202191302A1
EA202191302A1 EA202191302A EA202191302A EA202191302A1 EA 202191302 A1 EA202191302 A1 EA 202191302A1 EA 202191302 A EA202191302 A EA 202191302A EA 202191302 A EA202191302 A EA 202191302A EA 202191302 A1 EA202191302 A1 EA 202191302A1
Authority
EA
Eurasian Patent Office
Prior art keywords
midostaurine
mcl
inhibitor
combination
applications
Prior art date
Application number
EA202191302A
Other languages
Russian (ru)
Inventor
Энсар Халилович
Ючжэнь Ван
Эрик Моррис
Марина Коноплева
Анна Скварская
Original Assignee
Ле Лаборатуар Сервье
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье, Новартис Аг filed Critical Ле Лаборатуар Сервье
Priority claimed from PCT/EP2019/081291 external-priority patent/WO2020099542A1/en
Publication of EA202191302A1 publication Critical patent/EA202191302A1/en

Links

Abstract

Комбинация: (а) мидостаурина или его фармацевтически приемлемой соли, или его комплекса, или его сокристалла, или его сольвата, включая гидрат, и (б) ингибитора Mcl-1; и ее композиции и применения.A combination of: (a) midostaurine, or a pharmaceutically acceptable salt thereof, or a complex thereof, or a co-crystal thereof, or a solvate thereof, including a hydrate, and (b) an Mcl-1 inhibitor; and its composition and application.

EA202191302A 2019-10-08 2019-11-14 COMBINATION OF Mcl-1 INHIBITOR AND MIDOSTAURINE, ITS APPLICATIONS AND PHARMACEUTICAL COMPOSITIONS EA202191302A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962912160P 2019-10-08 2019-10-08
PCT/EP2019/081291 WO2020099542A1 (en) 2018-11-14 2019-11-14 Combination of a mcl-1 inhibitor and midostaurin, uses and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
EA202191302A1 true EA202191302A1 (en) 2021-10-01

Family

ID=78572626

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191302A EA202191302A1 (en) 2019-10-08 2019-11-14 COMBINATION OF Mcl-1 INHIBITOR AND MIDOSTAURINE, ITS APPLICATIONS AND PHARMACEUTICAL COMPOSITIONS

Country Status (1)

Country Link
EA (1) EA202191302A1 (en)

Similar Documents

Publication Publication Date Title
CY1123260T1 (en) A SODIUM SALT OF N-((1,2,3,5,6,7-EXAXPO-S-INDAKEN-4-YL)CARBAMOYL)-1-ISOPROPYL-1H-PYRAZOLE-3-SULFONAMIDE
EA201692437A1 (en) COMBINATION
EA201990851A1 (en) NEW CARBANUCLEOSIDE ANALOGUES REPLACED BY MONOCYCLIC AND BICYCLIC RING SYSTEM FOR USE AS PRMT5 INHIBITORS
CL2018002009A1 (en) Compounds derived from cyclopentane perhydrophenanthrene, fxr modulators; pharmaceutical composition comprising said compounds; and its use for the treatment of cholestatic, fibrotic, hypercholesterolemia diseases, among others.
EA201892395A1 (en) DRUG COMPOSITIONS OF LSD1 INHIBITOR
EA201992299A1 (en) COMPOUNDS BASED ON ASK1 INHIBITORS AND THEIR APPLICATION
EA201892450A1 (en) AROMATIC SULPHONAMIDE DERIVATIVES
EA202190960A1 (en) CONDENSED PYRROLINES THAT ACT AS INHIBITORS OF UBIKVITIN SPECIFIC PROTEASE 30 (USP30)
EA202092168A1 (en) APPLICATION OF FAVIPIRAVIR IN THE TREATMENT OF CORONAVIRUS INFECTION
JOP20200059A1 (en) Bisamide sarcomere activating compounds and uses thereof
EA202091400A1 (en) PYRROLE DERIVATIVES AS ACC INHIBITORS
EA202091256A1 (en) NEW ANTAGONISTS OF THE BRADIKININ RECEPTOR
EA201991700A1 (en) SELECTIVE INHIBITORS JAK1
EA202090119A1 (en) AMORPHIC AND CRYSTALLINE FORMS OF IDO INHIBITORS
CU20210016A7 (en) N-SUBSTITUTED DIOXOCYCLOBUTENYLAMINE-3-HYDROXY-PICOLINAMIDES USEFUL AS INHIBITORS OF CCR6
EA202190153A1 (en) AXL / MER INHIBITOR COMPOSITIONS
EA201890906A1 (en) DERIVATIVES OF CHINOXALINE AND PYRIDOPYRASINE AS PI3Kβ INHIBITORS
EA201692298A1 (en) DERIVATIVES OF CARBOXAMIDES
EA202191061A1 (en) pharmaceutical composition for oral administration containing dimethylamine A or a salt thereof
EA202092159A1 (en) CONTAINING N-HETEROCYCLIC FIVE-MERCHED RING CAPSID PROTEIN ASSEMBLY INHIBITOR, ITS PHARMACEUTICAL COMPOSITION AND THEIR APPLICATION
EA202090424A1 (en) BICYCLIC HISTONDEACETYLASE INHIBITORS
EA202190070A1 (en) BICYCLIC HISTONE DEACETYLASE INHIBITORS
EA202190064A1 (en) CYANOTRIAZOLE COMPOUNDS AND VARIANTS OF THEIR APPLICATION
EA202191192A1 (en) CRYSTALLINE SALTS OF PLASMA CALLICREIN INHIBITOR
EA202090995A1 (en) POLYCYCLIC AMIDES AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINE RECEPTORS